Join Akoya Biosciences at the World Clinical Biomarkers & Companion Diagnostics (CDx) Summit.
📍 Westin Seaport
425 Summer Street, Boston, MA 02210, United States
Attend our talk at the conference on Thursday, September 25, 2025, @ 11:50 a.m. ET
Advancing Multiplex Immunofluorescence: Akoya Biosciences is Pioneering Multiplex Immunofluorescence (mIF) Companion Diagnostic Development to Drive Key Clinical Decision Making
- Akoya Biosciences’ multiplex immunofluorescence technology enables high-plex, diagnostic biomarker analysis built upon the PhenoImager HT imaging instrument.
- CDx system development requires stringent controls and QC procedures to support multisite deployment capabilities and ensure patient safety.
- Akoya Biosciences is a capable diagnostic development partner with multiple late-stage clinical trials and CDx development programs—accelerating spatial diagnostic adoption in precision oncology.
Presenter
Mark Venghaus
Senior Director of CDx, Akoya Biosciences